New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Cyclo Therapeutics, Inc.
CYTH
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

34M

Drug Manufacturers - Specialty & Generic

Next Earning date - 17 Mar 2025

34M

Drug Manufacturers - Specialty & Generic

Next Earning date - 17 Mar 2025

1.13USD

Shape0.36 ( 46.75%)
Market Closed (as of Feb 07, 22:00 EDT)
favorite-chart

Relative Strenght

92
favorite-chart

Volume Buzz

182971%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

41%

Quote Panel

Shape
Updated February 9, 2025
1W % 1M % 3M % 1Y %

Key Metrics

Shape
  • Market Cap


  • Shares Outstanding


  • Share in Float


  • Dividende


  • Earning Date

    No Data


  • Price Target


  • Average Volume


  • Beta


  • Range


  • Industry


  • Website


  • Sector


Fundamentals

Shape

Relative Strength

Shape

CYTH

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$2M

Shape671%

2025-Revenue

$0.50

Shape-61%

2025-EPS

$2M

Shape78%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

H.C. Wainwright

downgrade

Previous: Not converted

2024-08-23

Now: Neutral

Morgan Stanley

downgrade

Previous: Not converted

2023-09-27

Now: Underweight

Maxim Group

upgrade

Previous: Not converted

2023-09-27

Now: Buy

Bernstein

initialise

Previous: Not converted

2023-03-21

Now: Market Perform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-0.59
vs -0.34

Q1.23

arrow
arrow

N/A

-0.46
vs -0.33

Q2.23

arrow
arrow

N/A

-0.33
vs -0.41

Q3.23

arrow
arrow

N/A

-0.29
vs -0.50

Q4.23

arrow
arrow

N/A

-0.23
vs -0.59

Q1.24

arrow
arrow

N/A

-0.15
vs -0.46

Q2.24

arrow
arrow

N/A

-0.21
vs -0.33

Q3.24

arrow
arrow

N/A

-0.26
vs -0.29

Q4.24

arrow
arrow

N/A

-0.12
vs -0.23

Q1.25

arrow
arrow

N/A

-0.19
vs -0.15

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

-68%

186.8K  vs 585.1K

Q1.23

arrow
arrow

-22%

152.4K  vs 194.9K

Q2.23

arrow
arrow

-78%

117.1K  vs 541.9K

Q3.23

arrow
arrow

+10%

495.5K  vs 452.2K

Q4.23

arrow
arrow

+67%

311.4K  vs 186.8K

Q1.24

arrow
arrow

+33%

202.4K  vs 152.4K

Q2.24

arrow
arrow

+5%

123.1K  vs 117.1K

Q3.24

arrow
arrow

-53%

233.8K  vs 495.5K

Q4.24

arrow
arrow

+74%

543K  vs 311.4K

Q1.25

arrow
arrow

-1%

200K  vs 202.4K

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-655%

-6.55
vs -0.76

Q1.23

arrow
arrow

+1141%

11.41
vs -6.55

Q2.23

arrow
arrow

+312%

3.12
vs 11.41

Q3.23

arrow
arrow

+453%

4.53
vs 3.12

Q4.23

arrow
arrow

-119%

-1.19
vs 4.53

Q1.24

arrow
arrow

-712%

-7.12
vs -1.19

Q2.24

arrow
arrow

+117%

1.17
vs -7.12

Q3.24

arrow
arrow

+66%

0.66
vs 1.17

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News